Archives

by in
Entry Author Date Location
Sanitas Gets FDA Clearance to Market ‘Wellaho’ for Chronically Ill 02/20/13 San Diego
Elcelyx Closes on $20M to Advance Appetite-Control Compounds 02/14/13 San Diego
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Ending the Culture of Illness through Healthy Eating 01/02/13 San Francisco
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Pfizer Invests in Rhythm to Support Diabetes, Obesity Drug Programs 11/27/12 Boston
East Coast Life Sciences Roundup: EpiCept, Boston Scientific, & More 11/09/12 Boston
San Diego Life Sciences Roundup: Accelrys, AirStrip, Ligand, & More 10/25/12 San Diego
Nutrition Initiative to Fund Exacting Research in What Makes Us Fat 09/25/12 San Diego
San Diego Life Sciences Roundup: Tandem Diabetes, Santarus, & More 09/13/12 San Diego
Alnylam, OmniGuide, Ginger Software, and More from the Boston Deals Roundup 08/29/12 Boston
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Elcelyx Therapeutics Raises $4M to Treat Obesity and Diabetes 08/13/12 San Diego
San Diego Life Sciences Roundup: Life, BioSurplus, Obalon, & More 07/19/12 San Diego
Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day 07/17/12 San Francisco
SD Life Sciences Roundup: Arena, PatientSafe, MEI Pharma, & More 06/28/12 San Diego
Arena Shares Boom on FDA Approval of Obesity Drug 06/27/12 San Diego
Can Your Friends Bribe You to Get Healthy? Neuroscience Says Yes 06/15/12 National
Rhythm Drums Up $25M to Advance Diabetes and Obesity Drugs 06/13/12 Boston
LoseIt, With 10M+ Users, Looks to Turn Weight Loss App Into Big Business 03/13/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Third Rock Looks to Fight Fat in a New Way, With Ember Therapeutics 12/15/11 Boston
Xconomist of the Week: Larry Smarr’s Quest for ‘Quantified Health’ 11/22/11 San Diego
Rhythm Adds Former Merck VP as CEO 11/09/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity 10/25/11 Boston
Orexigen’s Diet Drug Springs Back to Life, Independa Gets $1.6M, NuVasive Faces Big Judgments in Patent Dispute, & More San Diego Life Sciences News 09/22/11 San Diego
Orexigen Revives Obesity Drug After One More Go-Round With FDA 09/20/11 San Diego
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News 09/16/11 Boston
Page 1 of 6 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.